Experiments
Searchable full-text extractions: founding hypothesis, core claims, experimental setups, key results and statistics — pulled out of each paper as structure. Search a cell line, an assay or an entity (e.g. HUH7) and find every paper that worked with it. This corpus stands on its own: most entries carry no reproduction assessment (yet).
-
Full-text index only
Identify GDPD3 as a key regulator of epithelial-mesenchymal transition and prostate adenocarcinoma progression via the LPA/LPAR1/AKT axis: transcriptomic and experimental study.
PMID 41562071 · PMC12813044 · Frontiers in immunology · 2025 · 7 claims · 8 setups
GDPD3 is upregulated in PRAD tumor tissue and its knockdown inhibits tumor cell proliferation, invasion, and migration
-
Has reproduction · 66
STAT3-dependent analysis reveals PDK4 as independent predictor of recurrence in prostate cancer.
PMID 32323921 · PMC7178451 · Molecular systems biology · 2020 · 8 claims · 6 setups
Low STAT3 expression in primary PCa is associated with increased OXPHOS and ribosomal biosynthesis at the transcriptomic level
-
Full-text index only
Fibroblast-associated CTHRC1 as a key indicator of recurrence risk in prostate cancer.
PMID 41832493 · PMC13101373 · World journal of surgical oncology · 2026 · 7 claims · 8 setups
Pathological T stage, N stage, Gleason score, and TP53 mutation are associated with higher PRAD recurrence risk
-
Full-text index only
PVT1 lincRNA signals an androgen-dependent transcriptional activation program of oncogenes in prostate cancer cells.
PMID 41792045 · PMC13139993 · International journal of cancer · 2026 · 8 claims · 7 setups
PVT1 knockdown significantly reduces LNCaP cell proliferation and increases sensitivity to apoptosis
-
Has reproduction · 73
Detecting aberrant DNA methylation in Illumina DNA methylation arrays: a toolbox and recommendations for its use.
PMID 37218167 · PMC10208159 · Epigenetics · 2023 · 8 claims · 8 setups
Developed OutlierMeth, an R package that computes probe-specific thresholds and flags DNA methylation outliers from array data
-
Has reproduction · 62
scATD: a high-throughput and interpretable framework for single-cell cancer drug resistance prediction and biomarker identification.
PMID 40501071 · PMC12159290 · Briefings in bioinformatics · 2025 · 8 claims · 6 setups
scATD enables high-throughput single-cell drug sensitivity prediction for new patients without model parameter retraining via bidirectional Bi-AdaIN style transfer